0-46. The availability of oestrogen receptor (ER) status strongly influences recommendations for adjuvant systemic therapy in higher risk breast cancer patients

Autor:	A.N. Harnett, Arnie Purushotham, Gordon C. Wishart
Rok vydání:	1997
Předmět:	Oncology medicine.medical_specialty business.industry medicine.medical_treatment General Medicine medicine.disease Systemic therapy Breast cancer Internal medicine medicine Surgery Oestrogen receptor business Adjuvant
Zdroj:	The Breast. 6:237-238
ISSN:	0960-9776
DOI:	10.1016/s0960-9776(97)90627-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::eec62362678059e406edc5ee07381229 https://doi.org/10.1016/s0960-9776(97)90627-5 Zobrazit plný text záznamu Full Text from ScienceDirect